Andrea Tan

Stock Analyst at Goldman Sachs

(0.43)
# 2722
Out of 5,441 analysts
54
Total ratings
Success rate
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
INSM Insmed
Maintains: Strong Buy
114 142
112.87 25.81% 11 Aug 13, 2025
IOVA Iovance Biotherapeut...
Maintains: Buy
16 8
1.97 306.09% 7 May 12, 2025
TARS Tarsus Pharmaceutica...
Maintains: Neutral
46 51
50.08 1.84% 4 May 5, 2025
DAWN Day One Biopharmaceu...
Maintains: Buy
39 27
5.91 356.85% 6 Mar 25, 2025
SGMT Sagimet Biosciences
Maintains: Neutral
23 6
8.72 -31.19% 5 Jul 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
31
17.2 80.23% 1 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
3 2
0.56 257.14% 3 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Sell
2
8.04 -75.12% 1 Dec 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
17
31.23 -45.57% 1 Nov 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
160
137.58 16.3% 1 Nov 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 24
4.5 433.33% 2 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
10 4
0.94 325.53% 2 Jan 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
178 375
349.43 7.32% 1 Dec 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
13
11.13 16.8% 1 Dec 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
n/a n/a 6 Nov 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 4
1.99 101.01% 2 May 24, 2022